Last week was a busy time for Boston tech startups. Find out what companies are going public, raising new capital and bringing new tech jobs to the Boston area. This is the Built In Boston weekly refresh.
Biotech unicorn Ginkgo Bioworks is one of a new class of startups exploring the capabilities of synthetic biology. The company is now worth $4 billion after securing $290 million in additional funding.
When a company begins the merger and acquisition (M&A) process, the odds are not in its favor — some 70 to 90 percent of all M&A fail. Despite these odds, however, nearly 13,000 deals closed in 2018, many of which received some help from fintech firm SS&C Intralinks.
